Whether Serum Glial Fibrillary Acidic Protein (GFAP) Can Be Used as a Diagnostic Biomarker in Patients With Glioblastoma?

Whether Serum Glial Fibrillary Acidic Protein (GFAP) Can Be Used as a Diagnostic Biomarker in Patients With Glioblastoma?

Aim: To study if there is an increase in the serum levels of Glial Fibrillary Acidic Protein (GFAP) in patients with glioblastoma so that it can be used as a diagnostic biomarker for these cases. Design: Prospective observational study. Material and Methods: We prospectively examined 193 patients, o...

Full description

Bibliographic Details
Main Authors: Charandeep Singh Gandhoke, Ankit S Shah, Daljit Singh, Manju Subberwal, Rohit Kumar Gupta, Vinod Kumar Gupta, Ravindra K Saran
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:MAMC Journal of Medical Sciences
Subjects:
diagnostic biomarker
glioblastoma
glial fibrillary acidic protein (gfap)
serum
Online Access:http://www.mamcjms.in/article.asp?issn=2394-7438;year=2020;volume=6;issue=1;spage=27;epage=32;aulast=Gandhoke

Internet

http://www.mamcjms.in/article.asp?issn=2394-7438;year=2020;volume=6;issue=1;spage=27;epage=32;aulast=Gandhoke

Similar Items